Drug repurposing to overcome microbial resistance

Josef Jampilek1

  • 1Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovicova 6, 842 15 Bratislava, Slovakia; Department of Chemical Biology, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic.

Insights

Antimicrobial resistance is a growing global threat. This review explores drug repurposing as a strategy to combat resistant infections, examining its potential and limitations for developing new antibacterial drugs.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Drug Discovery

Background:

  • Antimicrobial resistance (AMR) is a significant global health challenge.
  • The emergence of multidrug-resistant pathogens ('superbugs') outpaces the development of new anti-infective drugs.
  • Existing treatments face limitations due to resistance and a lack of novel therapeutic agents.

Purpose of the Study:

  • To review the causes of antimicrobial resistance.
  • To discuss various approaches for discovering and developing new anti-infective drugs.
  • To critically evaluate drug repurposing as a strategy for combating antimicrobial resistance.

Main Methods:

  • Literature review summarizing causes of antimicrobial resistance.
  • Analysis of different strategies for anti-infective drug discovery and development.
  • Comprehensive overview of drugs from other indications tested for antimicrobial activity.
  • Critical assessment of repurposing non-antibiotics as antibacterial agents.

Main Results:

  • Antimicrobial resistance is driven by various factors, necessitating urgent solutions.
  • Drug repurposing shows promise by identifying existing drugs with potential antimicrobial activity.
  • Several non-antibiotic drugs have demonstrated in vitro activity, offering avenues for new therapeutic combinations.
  • Challenges and limitations exist in repurposing drugs for antibacterial applications.

Conclusions:

  • Drug repurposing is a viable strategy to address the antimicrobial resistance crisis.
  • Further research is needed to optimize and validate repurposed drugs for clinical use.
  • A multifaceted approach, including drug repurposing, is essential to combat the growing threat of infections.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
55.5K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
270
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
224
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
103
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
405
Transduction01:16

Transduction

Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
177